COVID-19: Won't stop clinical trials of plasma therapy as initial results are good, says Kejriwal

Image
Press Trust of India New Delhi
Last Updated : May 01 2020 | 12:54 PM IST

Chief Minister Arvind Kejriwal on Friday said the Delhi government will not stop clinical trials of plasma therapy to treat severally-ill COVID-19 patients as its initial results are good.

The announcement came days after the centre said that plasma therapy for treatment of coronavirus patients is at an experimental stage and it has the potential to cause life-threatening complications.

Addressing an online media briefing, Kejriwal said that one patient, whose condition was serious, has been discharged from hospital after undergoing plasma therapy.

"We are not going to stop clinical trials of plasma therapy. We are getting good results of the therapy. However, it is on trial basis," he said.

We are contacting 1,100 people who have recovered from COVID-19 to donate their plasma to save lives, he added.

We are conducting 2300 COVID-19 tests per 1 million people in Delhi, he said further.

To bring back students from Delhi who are stranded in Rajasthan's Kota - the coaching hub for engineering and medical aspirants the Delhi government will on Friday send 40 buses, the chief minister said.

The students will have to go into self-quarantine for 14 days upon returning to Delhi, he said.

He further said that free ration being provided to the needy in Delhi will be doubled to 10 kg.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 01 2020 | 12:54 PM IST

Next Story